Rockefeller Capital Management
IMUX icon

Rockefeller Capital Management’s Immunic IMUX Stock Holding History

Rockefeller Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Hold
100
– – ﹤0.01% 4472
2026
Q1 		$1.11K Hold
100
– – ﹤0.01% 4474
2025
Q4 		$534 Hold
100
– – ﹤0.01% 4521
2025
Q3 		$882 Buy
+100
New +$882 ﹤0.01% 4203

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Rockefeller Capital Management's IMUX Position: Q2 2026 in Review

Rockefeller Capital Management held its Immunic (IMUX) position steady in Q2 2026 at 100 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #4472.

Rockefeller Capital Management first reported a position in IMUX in Q3 2025 and has held it in 4 quarters since. 56 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Rockefeller Capital Management held 100 shares of Immunic worth $1.54K as of Q2 2026.
  • Rockefeller Capital Management left its Immunic share count unchanged in Q2 2026.
  • Immunic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4472 holding.
  • Rockefeller Capital Management first reported a position in Immunic in Q3 2025 and has held it in 4 quarters since.
  • 56 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.